We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Analysis Compared for Accurate Pleural Fluid pH Determination

By LabMedica International staff writers
Posted on 12 Mar 2019
Print article
Image: The pHOx Ultra blood gas analyzer is used for routine blood gas analysis (Photo courtesy of Nova Biomedical).
Image: The pHOx Ultra blood gas analyzer is used for routine blood gas analysis (Photo courtesy of Nova Biomedical).
Pleural effusion is the pathological accumulation of pleural fluid resulting from excess fluid production and/or increased transpleural pressure, increased capillary permeability, and impaired lymphatic drainage.

Pleural effusion occurs in many pulmonary or systemic diseases such as infection, liver cirrhosis, congestive heart failure, and malignancy. For assessment and differential diagnosis of the cause of pleural effusion, pleural fluid pH is one of the most useful indicators, along with the widely recommended indicators such as total protein, lactate dehydrogenase, and glucose levels.

Medical Laboratory Scientists at the Yonsei University College of Medicine (Seoul, Republic of Korea) evaluated from in- and out-patient samples obtained from thoracentesis or pigtail catheter drainage and submitted to the laboratory for routine body fluid analysis. The Clot Catcher, a disposable and single-use device designed to filter off microclots or debris, was inserted between the syringe and the blood gas analyzer.

The i-STAT G3+, a cartridge-based blood gas analyzer, was used as a reference analyzer for comparison with the other three methods. The i-Smart 300, a recently introduced cartridge-based blood gas analyzer, was evaluated for comparison. The Nova Biomedical pHOx Ultra now in use for routine arterial blood gas analysis in their laboratory, and pH indicator paper was also compared.

The scientists reported that the within-device precision of all three blood gas analyzers was acceptable within 0.1% according to the desirable precision criteria. For the i-STAT G3+, within-device CV(%) at low (pH 7.04) and high levels (pH 7.76) was 0.05% and 0.04%, respectively. For the pHOx Ultra, total CV(%) was 0.03% for all levels (pH 7.13, 7.35, and 7.59). For the i-Smart 300, total CV(%) at low, mid, and high levels (pH 7.13, 7.36 and 7.59, respectively) was 0.09%, 0.08%, and 0.09%, respectively.

The i-Smart 300 showed good agreement with i-STAT G3+, with a slope of 0.85 (95% CI, 0.800–0.906). The pHOx Ultra showed about 30% lower pH values than the i-STAT G3+. The slope of equation for pH indicator paper was 1.105, with a relatively wide range of 95% CI (0.781−1.581).

The authors concluded that pleural fluid pH determination using both blood gas analyzers, the i-Smart 300 and pHOx Ultra, is sufficiently accurate for diagnosing complicated parapneumonic effusion (CPPE), if pleural fluid is collected anaerobically in a heparinized syringe and a Clot Catcher is used to protect blood gas analyzers. The study was published on January 29, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Yonsei University College of Medicine

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TETANUS Test
TETANUS VIRCLIA IgG MONOTEST
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.